The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A.

Conclusion: Our results suggest a greater role of nongenetic factors in PTP inhibitor development. PMID: 31730688 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research